4//SEC Filing
Quimi Daphne 4
Accession 0001062993-24-016641
CIK 0001850119other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 4:18 PM ET
Size
4.8 KB
Accession
0001062993-24-016641
Insider Transaction Report
Form 4
Quimi Daphne
Director
Transactions
- Purchase
Common Stock
2024-09-12$1.53/sh+5,000$7,657→ 5,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.525 to $1.54. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
Issuer
Century Therapeutics, Inc.
CIK 0001850119
Entity typeother
Related Parties
1- filerCIK 0001543031
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 4:18 PM ET
- Size
- 4.8 KB